MYOS RENS Technology (NASDAQ:MYOS) opened at $1.25 on Monday. MYOS RENS Technology has a 52 week low of $1.03 and a 52 week high of $3.28.
Separately, ValuEngine raised MYOS RENS Technology from a “strong sell” rating to a “sell” rating in a research note on Friday, February 2nd.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3300650/myos-rens-technology-myos-set-to-announce-earnings-on-wednesday.html.
MYOS RENS Technology Inc, a bionutrition and biotherapeutics company, focuses on the discovery, development, and commercialization of nutritional and therapeutic products for maintaining and enhancing the health and performance of muscle tissue. The company primarily focuses on developing the products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity.
Receive News & Ratings for MYOS RENS Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYOS RENS Technology and related companies with MarketBeat.com's FREE daily email newsletter.